Centiva Capital’s Agilon Health AGL Stock Holding History

Centiva Capital’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547K	Buy	+5,108	New	+$335K	﹤0.01%	866
2025 Q2	–	Sell	-2,237	Closed	-$242K	–	1486
2025 Q1	$242K	Buy	+2,237	New	+$195K	0.01%	1198
2024 Q4	–	Sell	-6,627	Closed	-$651K	–	1625
2024 Q3	$651K	Buy	+6,627	New	+$856K	0.01%	1077
2024 Q1	–	Sell	-1,129	Closed	-$354K	–	1727
2023 Q4	$354K	Buy	+1,129	New	+$409K	0.01%	1129
2023 Q2	–	Sell	-526	Closed	-$312K	–	1595
2023 Q1	$312K	Buy	+526	New	+$295K	0.01%	1040
2022 Q3	–	Sell	-867	Closed	-$473K	–	1458
2022 Q2	$473K	Buy	+867	New	+$439K	0.01%	943
2022 Q1	–	Sell	-361	Closed	-$243K	–	1592
2021 Q4	$243K	Buy	+361	New	+$220K	0.01%	959
2021 Q3	–	Sell	-276	Closed	-$280K	–	1246
2021 Q2	$280K	Buy	+276	New	+$242K	0.01%	1073

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Centiva Capital's AGL Position: Q2 2026 in Review

Centiva Capital opened a new position in Agilon Health (AGL) in Q2 2026: 5,108 shares worth $547K. The stake represents ﹤0.01% of the portfolio and ranks #866 among its holdings. This is a return to the name: Centiva Capital previously reported a position in AGL as recently as Q1 2025.

Centiva Capital first reported a position in AGL in Q2 2021 and has held it in 8 quarters since. The position peaked at $651K in Q3 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Centiva Capital held 5,108 shares of Agilon Health worth $547K as of Q2 2026.
Agilon Health was a new Centiva Capital position in Q2 2026.
Agilon Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #866 holding.
Centiva Capital first reported a position in Agilon Health in Q2 2021 and has held it in 8 quarters since.
Centiva Capital's Agilon Health position peaked at $651K in Q3 2024.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.